Comments
Granules India has received approval from the US health regulator for generic Methocarbamol tablets in two strengths used for the treatment of muscle spasms and pain.
The USFDA has approved the abbreviated new drug application (ANDA) for Methocarbamol tablets in the strengths of 500 mg and 750 mg, Granules India said in a filing to the BSE.
The product is the generic version of Auxilium Pharmaceuticals LLC’s Robaxin tablets in the same strength The company intends to commercialise the product shortly, the filing said.
Shares of Granules India were trading at Rs 100.05 per scrip on BSE, down 0.30 per cent from the previous close.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.